Urimar-T (hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG) Oral Capsule, reformulated Oct 2013
- RxCUI
- 2640308
- RxNorm name
- Urimar-T (hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG) Oral Capsule, reformulated Oct 2013
- Display name
- Urimar-T (hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG) Oral Capsule, reformulated Oct 2013
- Full name
- Urimar-T (hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG) Oral Capsule, reformulated Oct 2013
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:22
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| URIMAR-T CAPS | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | Allegis Pharmaceuticals, LLC | cf7c3d65-11d2-49cd-b207-8ccc6a221fe0 | 2025-01-08 | Warnings, Adverse reactions | 2640308 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| cf7c3d65-11d2-49cd-b207-8ccc6a221fe0 | Urimar-T Oral Capsule, reformulated Oct 2013 [PSN] · hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule [Urimar Reformulated Oct 2013] [SBD] · Urimar-T (hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG) Oral Capsule, reformulated Oct 2013 [SY] | 3 | 3 | URIMAR-T™ CAPS | 20250108 |